R.J. Dearman - Concepedia

Author

R.J. Dearman

AstraZeneca (United Kingdom)

Also Known As

R DEARMAN, R Dearman, R J DEARMAN, R J Dearman, R. Dearman, R. J. Dearman, R.J. Dearman, Rebecca J. Dearman

Publications

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)GTx (United States)Unilever (United Kingdom)Salford Royal Hospital Syngenta (United Kingdom)

About

R.J. Dearman is an author at AstraZeneca (United Kingdom) specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	785
2	Cell Biology	9	9	422
3	Allergy	8	8	601
4	Allergy Medicine	3	3	276
5	Biostatistics	1	1	232

R.J. Dearman

Publications

Citations

H-Index

Page 1

	Year	Citations
A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses David A. Basketter, Linda J. Lea, Andrea Dickens, Journal of Applied Toxicology Allergy MedicineImmunologySkin AllergyDermatologyImmunotherapy	1999	232
Interleukin (IL)‐18 induces Langerhans cell migration by a tumour necrosis factor‐α‐ and IL‐1β‐dependent mechanism Marie Cumberbatch, R.J. Dearman, Christos Antonopoulos, Immunology ImmunologyImmune RegulationCell DeathPathologyImmunologic Mechanism	2001	182
The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma Lynnsey M Hamilton, Carlos Torres-Lozano, Sarah M. Puddicombe, Clinical & Experimental Allergy	2003	143
Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium Lynnsey M Hamilton, Sarah M. Puddicombe, R.J. Dearman, European Respiratory Journal	2005	59
Mechanistic relationship among mutagenicity, skin sensitization, and skin carcinogenicity. J. Ashby, Jennifer Hilton, R.J. Dearman, Environmental Health Perspectives Skin CarcinogenicitySkin AllergyDermatologyToxicological MechanismDrug Resistance	1993	48
The bronchial epithelium in asthma--much more than a passive barrier. Lynnsey M Hamilton, Donna E. Davies, Susan J. Wilson, PubMed AsthmaInflammatory Lung DiseaseLung InflammationMultifunctional RoleImmunology	2001	47
Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580 R.D. Koranteng, Emily J. Swindle, Beverley J. Davis, Clinical & Experimental Immunology Mast Cell DisorderImmunologyImmune RegulationInnate ImmunityInflammation	2004	42
Adhesion molecule expression by epidermal Langerhans cells and lymph node dendritic cells: a comparison Marie Cumberbatch, R.J. Dearman, Ian Kimber Archives of Dermatological Research Adhesion Molecule ExpressionCutaneous BiologyCell AdhesionCell InteractionImmunology	1996	40
Langerhans cell migration in mice requires intact type I interleukin 1 receptor (IL-1RI) function Marie Cumberbatch, R.J. Dearman, Ian Kimber Archives of Dermatological Research InflammationCytokineAutoimmune DiseaseMedicineImmunology	1999	34
Cytokine endpoints for the local lymph node assay: consideration of interferon-γ and interleukin 12 R.J. Dearman, Jennifer Hilton, David A. Basketter, Journal of Applied Toxicology Laboratory ImmunologyImmunodeficienciesImmunologyAllergenPathology	1999	26

Page 1